Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder

Pharmacopsychiatry

Volumn 29, Issue 5, 1996, Pages 193-195

  Walden, J ^a   Hesslinger, B ^a   Van Calker, D ^a   Berger, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; VALPROIC ACID;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BIPOLAR DEPRESSION; CASE REPORT; DRUG COMBINATION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029837862     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979570     Document Type: Article

References (17)

1. Brunet, G., B. Cerlich, P. Robert, S. Dumas, E. Souetre, G. Darcourt: Open trial of a calcium antagonist, nimodipine, in acute mania. Clin. Neuropharmacol. 13 (1990) 224-228
2. Calabrese, J. R., M. Woyshville, C. Bowden, L. Rhodes, S. McElroy, P. Keck, J. Cookseon, S. Kundu, J. Andersen, J. Ascher, C. Bolden-Watson, G. Paterson: Spectrum of efficacy of lamotrigine in treatment-refractory manic depression. Abstr. 2nd international conference on affective disorders. Jersualem 1995
3. + channels: local anaesthetics, antiarrhythmics and anticonvulsants. Trends Pharmacological Sci. 8 (1987) 57-65
4. Dubovsky, S. L.: Calcium antagonists in manic depressive illness. Neuropsychobiol. 27 (1993) 184-192
5. Gitlin, M. J., J. Swendsen, T. L. Heller, C. Hammen: Relapse and impairment in bipolar disorder. Amer. J. Psychiatry 152 (1995) 1635-1640
6. Harrow, M., J. F. Goldberg, L. S. Grossman, H. Y. Meltzer: Outcome in manic disorders: a naturalistic follow up study. Arch. Gen. Psychiatry 47 (1990) 665-671
7. Leach, M. J., C. M. Morden, A. A. Miller: Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II: Neurochemical studies on the mechanism of action. Epilepsia 27 (1986) 490-497
8. Lees, G., M. J. Leach: Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex. Brain Res. 612 (1993) 190-199
9. Rimmer, E., A. Richens: An update on sodium valproate. Pharmacotherapy 5 (1985) 171-184
10. Sachs, G. S.: Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J. Clin. Psychiatry 50 (1989) 31-39
11. 2+ response in neutrophils of manic-depressive patients: effect of lithium therapy. Neuropsychobiol. 27 (1993) 180-183
12. Wegerer, J. von, B. Hesslinger, J. Walden: Additive effects of lamotrigine with an organic calcium antagonist in in vitro epileptogenesis. Eur. J. Neurosci. Suppl. 8 (1995) 177
13. Walden, J., H. Grunze, A. Mayer, R. Düsing, K. Schirrmacher, D. Bingmann: Calciumantagonistic effects of carbamazepine in epilepsies and affective psychoses. Neuropsychobiol. 27 (1993) 171-175
14. Walden, J., J. Fritze, D. van Calker, M. Berger, H. Grunze: A calcium antagonist for the treatment of depressive episodes: single case reports. J. Psychiatr. Res. 29 (1995) 71-76
15. Warner, T., P. N. Patsalos, M. Prevett, A. A. Elyas, J. S. Duncan: Lamotrigine-induced carbamazepine toxicity; an interaction with carbamazepine-10,11-epoxide. Epilepsy Res. 11 (1992) 145-150
16. Weisler, R., M. E. Risner, J. Ascher, T. Houser: Use of lamotrigine in the treatment of bipolar disorder. Abstr. American Psychiatr. Ass., Philadelphia 1994
17. Yuen, A. W. C.: Lamotrigine: a review of antiepileptic efficacy. Epilepsia 35, Suppl. 5 (1994) S33-S36